Fluocinonide Ointment USP 0.05%
Reason Failed Impurities/Degradation - Out-of-specification results for Fluocinolone Acetonide impurity.
1,709 recalls · Class III, newest first
Reason Failed Impurities/Degradation - Out-of-specification results for Fluocinolone Acetonide impurity.
Reason Failed Impurties/Degradation Specifications: out of specification results for an impurity for one lot
Reason Presence of Foreign Tablets/Capsules: Metformin 1000mg with different imprint was found in bottles.
Reason Subpotent Drug: Product testing identified a decreased level of the active ingredient, Cysteamine HCl.
Reason Labeling: Product Contains Undeclared API; Incorrect formulation
Reason Subpotent Drug
Reason Failed Impurities/Degradation Specifications; high out of specification results obtained at the 9 month stability timepoint
Reason Labeling: Incorrect or Missing Package Insert: The package insert included in the finished product is for the Canadian market and is not part of the current approved drug labeling.
Reason Failed Stability Specifications: Out-of-Specification (OOS) results for the Aspirin related compound Salicylic Acid was observed.
Reason Failed Stability Specifications: Out-of-Specification (OOS) results for the Aspirin related compound Salicylic Acid was observed.
Reason Labeling; Not Elsewhere Classified: The Mentholatum Company is initiating a voluntary recall due to an error in the labeling of the cotton pellet box found within the Red Cross Oral Pain blister pack. The cotton pellet box states that the product contains "Natural Eugenol Oil" in which it does not.
Reason Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.
Reason Failed Tablet/Capsule Specifications: Tablets are imprinted with the incorrect identification code.
Reason Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.
Reason Labeling Error: Label Error on Declared Strength: Carton label and product insert incorrectly states the quantity of the excipient edetate disodium (EDTA) as 5.4 mg / vial, rather than the actual amount of 18.8 mg / vial.
Reason Cross contamination with other products - OOS discovered during routine stability testing for highest unknown impurity later identified as clozapine
Reason SUBPOTENT DRUG: Products failed assay results at the 12 and 24 month timepoints.
Reason SUBPOTENT DRUG: Products failed assay results at the 12 and 24 month timepoints.
Reason cGMP deviations: one lot of the product was distributed to US Markets despite being rejected during in-process control.
Reason Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification.
Reason Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification.
Reason TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.
Reason Labeling Not Elsewhere Classified: The statement Pharmacist: Dispense with the accompanying Medication Guide was not included on the carton label.
Reason Discoloration: Out of Specification (OOS) result for APHA Color Test.
Reason Failed Impurities/Degradation Specification: There is a slow leaching process from the product label on the bottle which may impact the product over the shelf life.